article · BMJ Public Health

Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study

Nadia Hachicha-Maalej
A. E. Ades
Sarah Pett
Diana M. Gibb
Aya Mostafa
Giuseppe Indolfi
Ali Judd
Clotilde Lepers
Intira Jeannie Collins
Karen Scott
Yazdan Yazdanpanah
Manal H. El‐Sayed
Sylvie Deuffic‐Burban

20241 citationOpen accessAin Shams University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Universal screening and treatment of HCV in pregnancy, with treatment of infected infants at age 3 years is cost saving compared with current practice in the Egyptian setting.

Research topics

Hepatitis C virus research
Liver Disease Diagnosis and Treatment
Liver Disease and Transplantation

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1136/bmjph-2023-000517

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.